DENTSPLY SIRONA (XRAY) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
The meeting was called to order and conducted virtually to enhance accessibility and communication for stockholders.
Key executives, board members, and audit partners from Deloitte were introduced, with roles clarified for the meeting.
Stockholders were informed about the process for submitting questions and voting during the meeting.
Shareholder proposals
Four proposals were presented: election of eleven directors, ratification of Deloitte as auditor, advisory vote on executive compensation, and amendment to the 2024 Omnibus Incentive Plan to increase share issuances.
Overview of voting outcomes
All eleven director nominees were elected by a majority of votes cast.
Deloitte's appointment as independent auditor was ratified by a majority vote.
The advisory vote on executive compensation for 2024 passed with a majority.
The amendment to the 2024 Omnibus Incentive Plan, increasing issuable shares by 11,260,000, was approved by a majority.
Final voting results will be disclosed in an upcoming SEC filing.
Latest events from DENTSPLY SIRONA
- Turnaround strategy centers on execution, innovation, and targeted investments for long-term growth.XRAY
Leerink Global Healthcare Conference 202610 Mar 2026 - Q4 2025 sales rose but FY 2025 declined; restructuring and dividend cut shift focus to growth.XRAY
Q4 202527 Feb 2026 - Transformation and digitalization drive growth, but implants continue to underperform.XRAY
43rd Annual J.P. Morgan Healthcare Conference 20253 Feb 2026 - Q2 sales fell 4.2% to $984M, with a net loss and new cost-saving restructuring underway.XRAY
Q2 20242 Feb 2026 - Transformation and digitalization target $200M+ savings and 500 bps margin growth by 2026.XRAY
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Primescan 2 launch and operational streamlining drive digital growth amid muted dental demand.XRAY
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Digital transformation and cloud innovation drive growth amid ongoing restructuring and market shifts.XRAY
Baird's 2024 Global Healthcare Conference21 Jan 2026 - Q3 sales rose 1.3%, but Byte suspension and a $495M impairment drove a $494M net loss.XRAY
Q3 202416 Jan 2026 - Turnaround plan drives digital innovation, DS Core expansion, and US growth in a $33B market.XRAY
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026